Ameritas Investment Partners Inc. Continues to Hold Position in Chemed Corp. (CHE)

Ameritas Investment Partners Inc. maintained its position in Chemed Corp. (NYSE:CHE) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,397 shares of the company’s stock at the end of the second quarter. Ameritas Investment Partners Inc.’s holdings in Chemed Corp. were worth $286,000 as of its most recent SEC filing.

Several other institutional investors also recently added to or reduced their stakes in CHE. Victory Capital Management Inc. grew its position in shares of Chemed Corp. by 23.9% during the 1st quarter. Victory Capital Management Inc. now owns 1,218 shares of the company’s stock valued at $223,000 after acquiring an additional 235 shares during the period. OppenheimerFunds Inc. grew its position in shares of Chemed Corp. by 5.4% during the 1st quarter. OppenheimerFunds Inc. now owns 6,564 shares of the company’s stock valued at $1,199,000 after acquiring an additional 334 shares during the period. Teachers Advisors LLC grew its position in shares of Chemed Corp. by 3.0% during the 1st quarter. Teachers Advisors LLC now owns 30,431 shares of the company’s stock valued at $5,559,000 after acquiring an additional 894 shares during the period. PNC Financial Services Group Inc. grew its position in shares of Chemed Corp. by 30.5% during the 1st quarter. PNC Financial Services Group Inc. now owns 3,650 shares of the company’s stock valued at $668,000 after acquiring an additional 854 shares during the period. Finally, Vanguard Group Inc. grew its position in shares of Chemed Corp. by 7.5% during the 1st quarter. Vanguard Group Inc. now owns 1,795,773 shares of the company’s stock valued at $328,070,000 after acquiring an additional 125,018 shares during the period. 96.94% of the stock is owned by hedge funds and other institutional investors.

A number of research firms have recently weighed in on CHE. KeyCorp reissued a “hold” rating on shares of Chemed Corp. in a research report on Friday. Royal Bank Of Canada reaffirmed a “hold” rating and issued a $209.00 price objective on shares of Chemed Corp. in a report on Tuesday, October 3rd. Oppenheimer Holdings, Inc. raised their price objective on shares of Chemed Corp. from $220.00 to $225.00 and gave the stock an “outperform” rating in a report on Friday. Zacks Investment Research downgraded shares of Chemed Corp. from a “buy” rating to a “hold” rating in a report on Tuesday, September 26th. Finally, BidaskClub downgraded shares of Chemed Corp. from a “buy” rating to a “hold” rating in a report on Wednesday, August 2nd. Four investment analysts have rated the stock with a hold rating and one has issued a buy rating to the company. Chemed Corp. presently has a consensus rating of “Hold” and a consensus price target of $216.67.

WARNING: This piece of content was reported by Community Financial News and is owned by of Community Financial News. If you are viewing this piece of content on another site, it was illegally copied and reposted in violation of US and international copyright & trademark law. The legal version of this piece of content can be read at https://www.com-unik.info/2017/10/29/ameritas-investment-partners-inc-continues-to-hold-position-in-chemed-corp-che.html.

In other Chemed Corp. news, insider Spencer S. Lee sold 1,000 shares of the company’s stock in a transaction that occurred on Friday, September 1st. The shares were sold at an average price of $197.46, for a total transaction of $197,460.00. Following the completion of the sale, the insider now directly owns 37,809 shares of the company’s stock, valued at $7,465,765.14. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director Patrick P. Grace sold 500 shares of the company’s stock in a transaction that occurred on Monday, October 2nd. The shares were sold at an average price of $201.48, for a total transaction of $100,740.00. Following the sale, the director now directly owns 4,515 shares of the company’s stock, valued at $909,682.20. The disclosure for this sale can be found here. 4.90% of the stock is currently owned by corporate insiders.

Chemed Corp. (NYSE CHE) opened at 232.20 on Friday. The company has a 50-day moving average of $200.95 and a 200 day moving average of $199.75. Chemed Corp. has a 12-month low of $132.92 and a 12-month high of $233.50. The company has a market capitalization of $3.71 billion, a P/E ratio of 57.60 and a beta of 1.13.

Chemed Corp. (NYSE:CHE) last announced its earnings results on Thursday, October 26th. The company reported $2.15 EPS for the quarter, beating the Zacks’ consensus estimate of $2.00 by $0.15. Chemed Corp. had a net margin of 4.62% and a return on equity of 27.49%. The business had revenue of $417.40 million during the quarter, compared to analysts’ expectations of $414.34 million. During the same period in the prior year, the company earned $1.73 earnings per share. The firm’s revenue was up 6.3% on a year-over-year basis. Equities research analysts forecast that Chemed Corp. will post $8.21 earnings per share for the current fiscal year.

Chemed Corp. Company Profile

Chemed Corporation purchases, operates and divests subsidiaries engaged in various business activities. The Company operates through two segments: the VITAS segment (VITAS) and the Roto-Rooter segment (Roto-Rooter). The Company’s VITAS provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers.

Want to see what other hedge funds are holding CHE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chemed Corp. (NYSE:CHE).

Institutional Ownership by Quarter for Chemed Corp. (NYSE:CHE)

What are top analysts saying about Chemed Corp.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Chemed Corp. and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit